Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well bendamustine hydrochloride, obinutuzumab, and
dexamethasone work in treating older patients with diffuse large B-cell lymphoma. Drugs used
in chemotherapy, such as bendamustine hydrochloride and dexamethasone, work in different ways
to stop the growth of cancer cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading. Monoclonal antibodies, such as obinutuzumab,
may find cancer cells and help kill them. Giving bendamustine hydrochloride, obinutuzumab,
and dexamethasone may kill more cancer cells.